Insulin-Dependent Diabetes Mellitus as an Autoimmune Disease, Endocrine Reviews, vol.15, issue.4, pp.516-542, 1994. ,
DOI : 10.1210/edrv-15-4-516
Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial, Lancet, vol.2, pp.119-124, 1986. ,
??-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial, The Lancet, vol.358, issue.9295, pp.1749-1753, 2001. ,
DOI : 10.1016/S0140-6736(01)06801-5
The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group, Diabetes, vol.47, issue.6, pp.980-984, 1998. ,
DOI : 10.2337/diabetes.47.6.980
Oral insulin administration and residual (??-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial, The Lancet, vol.356, issue.9229, pp.545-549, 2000. ,
DOI : 10.1016/S0140-6736(00)02579-4
No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII), Diabetologia, vol.43, issue.8, pp.1000-1004, 2000. ,
DOI : 10.1007/s001250051482
Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study, Diabetes Care, vol.22, issue.10, pp.1703-1707, 1999. ,
DOI : 10.2337/diacare.22.10.1703
Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens, Annual Review of Immunology, vol.12, issue.1, pp.809-837, 1994. ,
DOI : 10.1146/annurev.iy.12.040194.004113
Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum., Proceedings of the National Academy of Sciences, vol.89, issue.8, pp.3434-3438, 1992. ,
DOI : 10.1073/pnas.89.8.3434
Autoimmune Diabetes in NOD Mouse Is L3T4 T-Lymphocyte Dependent, Diabetes, vol.36, issue.4, pp.535-538, 1987. ,
DOI : 10.2337/diab.36.4.535
Anti-??/?? T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice, European Journal of Immunology, vol.85, issue.5, pp.1163-1169, 1991. ,
DOI : 10.1002/eji.1830210511
Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention, Cell, vol.54, issue.2, pp.263-273, 1988. ,
DOI : 10.1016/0092-8674(88)90558-2
A Human Endogenous Retroviral Superantigen as Candidate Autoimmune Gene in Type I Diabetes, Cell, vol.90, issue.2, pp.303-313, 1997. ,
DOI : 10.1016/S0092-8674(00)80338-4
Prevention of diabetes in non-obese diabetic I-Ak transgenic mice, Nature, vol.345, issue.6277, pp.724-726, 1990. ,
DOI : 10.1038/345724a0
An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells., CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes, pp.9566-9570285, 1993. ,
DOI : 10.1073/pnas.90.20.9566
B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes, Immunity, vol.12, issue.4, pp.431-440, 2000. ,
DOI : 10.1016/S1074-7613(00)80195-8
Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice, Diabetes, vol.45, issue.6, pp.812-817, 1996. ,
DOI : 10.2337/diabetes.45.6.812
Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice, Diabetes, vol.49, issue.12, pp.2007-2011, 2000. ,
DOI : 10.2337/diabetes.49.12.2007
Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice, J Immunol, vol.163, pp.2960-2968, 1999. ,
Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice, Journal of Experimental Medicine, vol.179, issue.4, pp.1379-1384, 1994. ,
DOI : 10.1084/jem.179.4.1379
A noncytolytic IL- 10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice, J Immunol, vol.158, pp.4507-4513, 1997. ,
Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice, J Immunol, vol.163, pp.5125-5132, 1999. ,
Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1., Proceedings of the National Academy of Sciences, vol.87, issue.3, pp.968-972, 1990. ,
DOI : 10.1073/pnas.87.3.968
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process, Journal of Experimental Medicine, vol.180, issue.3, pp.995-1004, 1994. ,
DOI : 10.1084/jem.180.3.995
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice., Proceedings of the National Academy of Sciences, vol.91, issue.1, pp.123-127, 1994. ,
DOI : 10.1073/pnas.91.1.123
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice, J Immunol, vol.158, pp.2947-2954, 1997. ,
The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to ?? cells in NOD mice, European Journal of Immunology, vol.18, issue.7, pp.1913-1918, 1992. ,
DOI : 10.1002/eji.1830220735
HOW DO MONOCLONAL ANTIBODIES INDUCE TOLERANCE? A Role for Infectious Tolerance?, Annual Review of Immunology, vol.16, issue.1, pp.619-644, 1998. ,
DOI : 10.1146/annurev.immunol.16.1.619
Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse, European Journal of Immunology, vol.19, issue.12, pp.2989-2998, 1996. ,
DOI : 10.1002/eji.1830261226
Herbelin A: Activation of natural killer T cells by ? ?-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes, Nature Medicine, vol.7, issue.9, pp.1057-1062, 2001. ,
DOI : 10.1038/nm0901-1057
Aerosol Insulin Induces Regulatory CD8 gamma delta T Cells That Prevent Murine Insulin-dependent Diabetes, Journal of Experimental Medicine, vol.184, issue.6, pp.2167-2174, 1996. ,
DOI : 10.1084/jem.184.6.2167
Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice, J Immunol, vol.150, pp.2072-2080, 1993. ,
Neonatal induction of allogeneic tolerance prevents T cell-mediated autoimmunity in NOD mice, European Journal of Immunology, vol.213, issue.4, pp.611-616, 1989. ,
DOI : 10.1002/eji.1830190406
Regulation of Autoimmune Diabetes by Interleukin 3-dependent Bone Marrow-derived Cells in NOD Mice, Journal of Autoimmunity, vol.10, issue.4, pp.331-338, 1997. ,
DOI : 10.1006/jaut.1997.0142
Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice, Diabetes, vol.41, issue.12, pp.1672-1676, 1992. ,
DOI : 10.2337/diabetes.41.12.1672
Prevention of Diabetes and Insulitis by Neonatal Intrathymic Islet Administration in NOD Mice, Journal of Autoimmunity, vol.7, issue.5, pp.549-560, 1994. ,
DOI : 10.1006/jaut.1994.1040
Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes, Science, vol.240, issue.4852, pp.659-662, 1988. ,
DOI : 10.1126/science.2966437
The involvement of Ly 2+ T cells in beta cell destruction, Journal of Autoimmunity, vol.3, pp.101-109, 1990. ,
DOI : 10.1016/S0896-8411(09)90018-X
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody, Proceedings of the National Academy of Sciences, vol.42, issue.4, pp.285-290, 2000. ,
DOI : 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z
T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse, International Immunology, vol.5, issue.5, pp.479-489, 1993. ,
DOI : 10.1093/intimm/5.5.479
Prevention of Diabetes Mellitus in the Non-obese Diabetic Mouse Strain with Monoclonal Antibodies Against the CD45RB Molecule, Autoimmunity, vol.20, issue.1, pp.73-76, 2000. ,
DOI : 10.3109/08916930008995990
Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody, Jikken Dobutsu, vol.4, pp.501-504, 1986. ,
<b>The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) </b><b>mice </b>, Biomedical Research, vol.6, issue.2, pp.103-105, 1985. ,
DOI : 10.2220/biomedres.6.103
Anti-CD43 monoclonal antibody L11 blocks migration of T cells to inflamed pancreatic islets and prevents development of diabetes in nonobese diabetic mice, J Immunol, vol.163, pp.5678-5685, 1999. ,
Administration of Monoclonal Antibodies against Vascular Cell Adhesion Molecule-1/Very Late Antigen-4 Abrogates Predisposing Autoimmune Diabetes in NOD Mice, Cellular Immunology, vol.165, issue.2, pp.193-201, 1995. ,
DOI : 10.1006/cimm.1995.1205
Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors., Proceedings of the National Academy of Sciences, vol.90, issue.22, pp.10494-10498, 1993. ,
DOI : 10.1073/pnas.90.22.10494
Vascular cell adhesion molecule-Ig fusion protein selectively targets activated alpha 4-integrin receptors in vivo. Inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice, J Immunol, vol.155, pp.938-946, 1995. ,
Preventive effects of Cyclosporin on diabetes in NOD mice, Diabetologia, vol.60, issue.4, pp.244-247, 1986. ,
DOI : 10.1007/BF00454884
Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice, Diabetologia, vol.60, issue.Suppl. 6, pp.503-505, 1990. ,
DOI : 10.1007/BF00405113
Preventive effects of azathioprine (AZA) on the onset of diabetes mellitus in NOD mice, Journal of Endocrinological Investigation, vol.322, issue.1, pp.869-873174, 1992. ,
DOI : 10.1007/BF03348947
Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin, Clinical & Experimental Immunology, vol.2, issue.2, pp.232-236, 1993. ,
DOI : 10.1111/j.1365-2249.1993.tb05888.x
Prevention of Type I Diabetes by Low-Dose Gamma Irradiation in NOD Mice, Radiation Research, vol.154, issue.6, pp.680-685, 2000. ,
DOI : 10.1667/0033-7587(2000)154[0680:POTIDB]2.0.CO;2
Prevention of Cyclophosphamide-Induced Diabetes by Anti-V??8 T-Lymphocyte-Receptor Monoclonal Antibody Therapy in NOD/Wehi Mice, Diabetes, vol.38, issue.11, pp.1492-1495, 1989. ,
DOI : 10.2337/diab.38.11.1492
Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus, Diabetologia, vol.40, issue.12, pp.1388-1395, 1997. ,
DOI : 10.1007/s001250050840
Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse, Immunology, vol.80, pp.498-501, 1993. ,
T cell vaccination against autoimmune diabetes in nonobese diabetic mice, Ann Clin Lab Sci, vol.23, pp.137-147, 1993. ,
Prevention of Diabetes in the NOD Mouse by a Th1 Clone Specific for a hsp60 Peptide, Journal of Autoimmunity, vol.14, issue.2, pp.133-142, 2000. ,
DOI : 10.1006/jaut.1999.0352
Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides, Journal of Experimental Medicine, vol.182, issue.3, pp.897-902, 1995. ,
DOI : 10.1084/jem.182.3.897
Prevention of Cyclophosphamide-Induced and Spontaneous Diabetes in NOD/Shi/Kbe Mice by Anti-MHC Class I Kd Monoclonal Antibody, Diabetes, vol.40, issue.9, pp.1203-1209, 1991. ,
DOI : 10.2337/diab.40.9.1203
Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells., Proceedings of the National Academy of Sciences, vol.85, issue.24, pp.9719-9723, 1988. ,
DOI : 10.1073/pnas.85.24.9719
Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules., Proceedings of the National Academy of Sciences, vol.89, issue.20, pp.9519-9523, 1992. ,
DOI : 10.1073/pnas.89.20.9519
Prevention of diabetes in NOD mice by a mutated I-Ab transgene, Diabetes, vol.47, issue.10, pp.1570-1577, 1998. ,
DOI : 10.2337/diabetes.47.10.1570
Prevention of autoimmune insulitis by expression of I???E molecules in NOD mice, Nature, vol.328, issue.6129, pp.432-434, 1987. ,
DOI : 10.1038/328432a0
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism., Journal of Clinical Investigation, vol.100, issue.9, pp.2243-2253, 1997. ,
DOI : 10.1172/JCI119762
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse, Journal of Experimental Medicine, vol.181, issue.3, pp.1145-1155, 1995. ,
DOI : 10.1084/jem.181.3.1145
CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice, J Immunol, vol.159, pp.4620-4627, 1997. ,
Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb, International Immunology, vol.6, issue.6, pp.831-838, 1994. ,
DOI : 10.1093/intimm/6.6.831
Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes, Diabetologia, vol.41, issue.11, pp.1298-1303, 1998. ,
DOI : 10.1007/s001250051068
Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages, Nature, vol.348, issue.6302, pp.639-642, 1990. ,
DOI : 10.1038/348639a0
Prevention of diabetes in NOD mice treated with antibody to murine IFN??, Journal of Autoimmunity, vol.4, issue.2, pp.237-248, 1991. ,
DOI : 10.1016/0896-8411(91)90021-4
Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice., Journal of Clinical Investigation, vol.87, issue.2, pp.739-742, 1991. ,
DOI : 10.1172/JCI115055
Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein, Gene Therapy, vol.6, issue.5, pp.771-777, 1999. ,
DOI : 10.1038/sj.gt.3300879
Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis, J Immunol, vol.140, pp.59-61, 1988. ,
IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice, J Immunol, vol.163, pp.4041-4048, 1999. ,
Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice, European Journal of Immunology, vol.49, issue.3, pp.697-702, 1992. ,
DOI : 10.1002/eji.1830220312
Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice, Diabetes, vol.49, issue.12, pp.1998-2006, 2000. ,
DOI : 10.2337/diabetes.49.12.1998
Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40) 2, Diabetologia, vol.40, issue.6, pp.641-646, 1997. ,
DOI : 10.1007/s001250050728
Ingested interferon ?? suppresses Type I diabetes in non-obese diabetic mice, Diabetologia, vol.41, issue.10, pp.1227-1232, 1998. ,
DOI : 10.1007/s001250051056
Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic mice, Diabetes, vol.46, issue.6, pp.937-940, 1997. ,
DOI : 10.2337/diabetes.46.6.937
IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice, Clinical and Experimental Immunology, vol.108, issue.2, pp.314-317, 1997. ,
DOI : 10.1046/j.1365-2249.1997.3771275.x
Reversal of Spontaneous Autoimmune Insulitis in Nonobese Diabetic Mice by Soluble Lymphotoxin Receptor, The Journal of Experimental Medicine, vol.231, issue.11, pp.1327-1332, 2001. ,
DOI : 10.1038/73136
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice, Journal of Experimental Medicine, vol.178, issue.1, pp.87-99, 1993. ,
DOI : 10.1084/jem.178.1.87
COMBINED THERAPY WITH INTERLEUKIN-4 AND INTERLEUKIN-10 INHIBITS AUTOIMMUNE DIABETES RECURRENCE IN SYNGENEIC ISLET-TRANSPLANTED NONOBESE DIABETIC MICE ANALYSIS OF CYTOKINE MRNA EXPRESSION IN THE GRAFT, Transplantation, vol.60, issue.4, pp.368-374, 1995. ,
DOI : 10.1097/00007890-199508270-00012
Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse, Clinical Immunology and Immunopathology, vol.71, issue.2, pp.169-175, 1994. ,
DOI : 10.1006/clin.1994.1068
Interleukin-13 prevents autoimmune diabetes in NOD mice, Diabetes, vol.48, issue.8, pp.1522-1528, 1999. ,
DOI : 10.2337/diabetes.48.8.1522
Effects of BCG, lymphotoxin and bee venom on insulitis and development of IDDM in non-obese diabetic mice, Journal of Korean Medical Science, vol.14, issue.6, pp.648-652, 1999. ,
DOI : 10.3346/jkms.1999.14.6.648
Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice, Diabetes, vol.48, issue.12, pp.2333-2339, 1999. ,
DOI : 10.2337/diabetes.48.12.2333
Exogenous Administration of Il-L?? Inhibits Active and Adoptive Transfer Autoimmune Diabetes in Nod Mice, Autoimmunity, vol.58, issue.1, pp.21-27, 1992. ,
DOI : 10.1016/S0065-2776(08)60342-9
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin., Proceedings of the National Academy of Sciences, vol.88, issue.22, pp.10252-10256, 1991. ,
DOI : 10.1073/pnas.88.22.10252
Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes, International Immunology, vol.13, issue.6, pp.825-833, 2001. ,
DOI : 10.1093/intimm/13.6.825
Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)., Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.956-960, 1996. ,
DOI : 10.1073/pnas.93.2.956
Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription., Journal of Clinical Investigation, vol.95, issue.2, pp.628-634, 1995. ,
DOI : 10.1172/JCI117707
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice., Journal of Clinical Investigation, vol.100, issue.6, pp.1344-1348, 1997. ,
DOI : 10.1172/JCI119654
Immunization with DNA Encoding an Immunodominant Peptide of Insulin Prevents Diabetes in NOD Mice, Clinical Immunology, vol.100, issue.2, pp.164-171, 2001. ,
DOI : 10.1006/clim.2001.5055
Transgenic Expression of Mouse Proinsulin II Prevents Diabetes in Nonobese Diabetic Mice, Diabetes, vol.46, issue.1, pp.34-39, 1997. ,
DOI : 10.2337/diab.46.1.34
A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes, Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.4610-4614, 1997. ,
DOI : 10.1073/pnas.93.2.956
Effect of Oral and Intravenous Insulin and Glutamic Acid Decarboxylase in NOD Mice, Autoimmunity, vol.78, issue.2, pp.139-151, 1997. ,
DOI : 10.1080/01621459.1958.10501452
Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes, Journal of Experimental Medicine, vol.183, issue.4, pp.1561-1567, 1996. ,
DOI : 10.1084/jem.183.4.1561
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes, Nature, vol.366, issue.6450, pp.69-72, 1993. ,
DOI : 10.1038/366069a0
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice, Nature, vol.366, issue.6450, pp.72-75, 1993. ,
DOI : 10.1038/366072a0
Effects of Plasmid DNA Injection on Cyclophosphamide-Accelerated Diabetes in NOD Mice, DNA and Cell Biology, vol.20, issue.3, pp.175-81, 2001. ,
DOI : 10.1089/104454901300069022
Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice, Pharmaceutical Research, vol.16, issue.7, pp.1059-1066, 1999. ,
DOI : 10.1023/A:1018939900961
Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein., Proceedings of the National Academy of Sciences, vol.87, issue.4, pp.1576-1580, 1990. ,
DOI : 10.1073/pnas.87.4.1576
Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) Mice, Diabetes, vol.31, issue.9, pp.749-753, 1982. ,
DOI : 10.2337/diab.31.9.749
Vitamin E supplementation reduces the incidence of diabetes but not insulitis in NOD mice, J Lab Clin Med, vol.119, pp.503-507, 1992. ,
Antioxidant MDL 29,311 Prevents Diabetes in Nonobese Diabetic and Multiple Low-Dose STZ-Injected Mice, Diabetes, vol.42, issue.12, pp.1721-1730, 1993. ,
DOI : 10.2337/diab.42.12.1721
Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in NOD mice, Life Sciences, vol.51, issue.25, pp.1937-1943, 1992. ,
DOI : 10.1016/0024-3205(92)90110-B
Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process., Proceedings of the National Academy of Sciences, vol.90, issue.19, pp.8992-8995, 1993. ,
DOI : 10.1073/pnas.90.19.8992
The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice, Diabetes, vol.47, issue.4, pp.570-575, 1998. ,
DOI : 10.2337/diabetes.47.4.570
Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug, Diabetologia, vol.53, issue.12, pp.1195-1201, 1994. ,
DOI : 10.1007/BF00399792
An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice, Diabetologia, vol.141, issue.12, pp.713-718, 1990. ,
DOI : 10.1007/BF00400340
Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D- glucan and rhIGF-I, J Pediatr Endocrinol Metab, vol.11, issue.2, pp.327-333, 1998. ,
MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice, Diabetologia, vol.44, issue.7, pp.839-886, 2001. ,
DOI : 10.1007/s001250100519
Immunotherapy with ciamexon in the non obese diabetic (NOD) mouse. Hormone Metab Res, pp.1-4, 1992. ,
Induction of Tolerance in Macrophages by Cholera Toxin B Chain, Pathobiology, vol.67, issue.5-6, pp.314-317, 1999. ,
DOI : 10.1159/000028088
The B-Subunit of Cholera Toxin Induces Immunoregulatory Cells and Prevents Diabetes in the NOD Mouse, Diabetes, vol.47, issue.2, pp.186-191, 1998. ,
DOI : 10.2337/diab.47.2.186
Attempt to prevent the development of diabetes in non-obese diabetic mice by oral vanadate administration, Israel Med Assoc J, vol.2, pp.211-214, 2000. ,
Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D-3 in combination with a short induction course of cyclosporin A, Endocrinology, vol.139, pp.95-102, 1998. ,
Androgen treatment prevents diabetes in nonobese diabetic mice, Journal of Experimental Medicine, vol.175, issue.5, pp.1409-1412, 1992. ,
DOI : 10.1084/jem.175.5.1409
Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse, Journal of Autoimmunity, vol.4, issue.5, pp.733-742, 1991. ,
DOI : 10.1016/0896-8411(91)90169-D
Immunoglobulin-Mediated Prevention of Autoimmune Diabetes in the Non-Obese Diabetic (NOD) Mouse, Scandinavian Journal of Immunology, vol.17, issue.4, pp.445-451, 1991. ,
DOI : 10.1084/jem.135.2.277
Inhibition of Diabetes in NOD Mice by Idiotypic Induction of SLE, Journal of Autoimmunity, vol.13, issue.1, pp.49-55, 1999. ,
DOI : 10.1006/jaut.1999.0292
Lipopolysaccharide-Activated B Cells Down-Regulate Th1 Immunity and Prevent Autoimmune Diabetes in Nonobese Diabetic Mice, The Journal of Immunology, vol.167, issue.2, pp.1081-1089, 2001. ,
DOI : 10.4049/jimmunol.167.2.1081
Homeostasis as regulated by activated macrophage. V. Suppression of diabetes mellitus in nonobese diabetic mice by LPSw (a lipopolysaccharide from wheat flour) Chem Pharmaceut Bull, pp.1004-1006, 1992. ,
Dietary protection against diabetes in NOD mice: lack of a major change in the immune system, Diabete Metab, vol.21, pp.261-268, 1995. ,
Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice, British Journal of Nutrition, vol.2, issue.02, pp.597-607, 1993. ,
DOI : 10.1016/S0022-3476(74)80462-2
Treatment with Sulfatide or its Precursor, Galactosylceramide, Prevents Diabetes in NOD Mice, Autoimmunity, vol.188, issue.1, pp.9-17, 2001. ,
DOI : 10.2337/diab.39.8.933
Preventive Effect of Ninjin-to (Ren-Shen-Tang), a Kampo (Japanese Traditional) Formulation, on Spontaneous Autoimmune Diabetes in Non-Obese Diabetic (NOD) Mice, Microbiology and Immunology, vol.13, issue.4, pp.299-305, 2000. ,
DOI : 10.1111/j.1348-0421.2000.tb02499.x
Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide, Diabetes, vol.37, issue.7, pp.930-935, 1988. ,
DOI : 10.2337/diabetes.37.7.930
Gangliosides in vivo reduce diabetes incidence in non-obese diabetic mice, Diabetologia, vol.31, issue.11, pp.855-857, 1988. ,
DOI : 10.1007/BF00277490
Antiasialo GM1 antibody suppression of cyclophosphamideinduced diabetes in NOD mice, Diabetes Res, vol.17, pp.37-41, 1991. ,
Studies of concanavalin A in nonobese diabetic mice. I. Prevention of insulin-dependent diabetes, J Pharmacol Exp Ther, vol.258, pp.710-715, 1991. ,